On May 29, the U.S. Food and Drug Administration (FDA) announces that injectable drugs used in total parenteral nutrition (TPN) will be imported into the U.S. to help ease shortages. The FDA is allowing Fresenius Kabi USA, LLC, to import trace elements and phosphate injection from its Norway plant. Read more.
FDA announces import of injectable drugs used in TPN to ease shortage
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
